Financial results - CABINET MEDICAL NERVASYST SRL

Financial Summary - Cabinet Medical Nervasyst Srl
Unique identification code: 35713422
Registration number: J35/594/2016
Nace: 8622
Sales - Ron
48.824
Net Profit - Ron
34.581
Employee
The most important financial indicators for the company Cabinet Medical Nervasyst Srl - Unique Identification Number 35713422: sales in 2023 was 48.824 euro, registering a net profit of 34.581 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Cabinet Medical Nervasyst Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 11.954 6.775 8.074 16.422 23.074 36.266 47.183 48.824
Total Income - EUR - - 11.954 6.775 8.074 16.422 23.074 36.266 47.183 48.824
Total Expenses - EUR - - 2.951 2.615 3.051 5.201 4.284 3.617 5.234 13.755
Gross Profit/Loss - EUR - - 9.002 4.161 5.023 11.221 18.790 32.650 41.949 35.069
Net Profit/Loss - EUR - - 8.644 3.958 4.780 10.729 18.142 31.583 40.800 34.581
Employees - - 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 3.8%, from 47.183 euro in the year 2022, to 48.824 euro in 2023. The Net Profit decreased by -6.095 euro, from 40.800 euro in 2022, to 34.581 in the last year.

Check the financial reports for the company - Cabinet Medical Nervasyst Srl

Rating financiar

Financial Rating -
Cabinet Medical Nervasyst Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Cabinet Medical Nervasyst Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Cabinet Medical Nervasyst Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Cabinet Medical Nervasyst Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Cabinet Medical Nervasyst Srl - CUI 35713422

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 704 512 325 0 0 0 0 0
Current Assets - - 8.375 12.346 17.775 11.947 19.503 31.919 41.063 46.165
Inventories - - 0 0 171 0 0 0 0 0
Receivables - - 3.560 6.550 10.749 5.268 4.366 18.533 37.002 22.305
Cash - - 4.815 5.796 6.855 6.679 15.137 13.386 4.061 23.860
Shareholders Funds - - 8.688 12.499 17.050 10.779 18.192 31.632 40.849 44.912
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 391 359 1.051 1.168 1.312 287 215 1.253
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 46.165 euro in 2023 which includes Inventories of 0 euro, Receivables of 22.305 euro and cash availability of 23.860 euro.
The company's Equity was valued at 44.912 euro, while total Liabilities amounted to 1.253 euro. Equity increased by 4.187 euro, from 40.849 euro in 2022, to 44.912 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Cabinet Medical Nervasyst Srl

Comments - Cabinet Medical Nervasyst Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.